US appeals court rules against Apotex on Risperdal oral
This article was originally published in Scrip
Executive Summary
In another saga involving declaratory judgements, the US appeals court has affirmed a lower court decision and has agreed that no jurisdiction exists forApotex's declaratory judgement action regardingJanssen's antipsychotic Risperdal (risperidone) oral solution and patents listed in the Orange Book.